Risk factors and drug discovery for cognitive impairment in type 2 diabetes mellitus using artificial intelligence interpretation and graph neural networks

BACKGROUND: Among the 382 million diabetic patients worldwide, approximately 30% experience neuropathy, and one-fifth of these patients eventually develop diabetes cognitive impairment (CI). However, the mechanism underlying diabetes CI remains unknown, and early diagnostic methods or effective trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xin, Xie, Jiajia, You, Xiong, Gong, Houwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485700/
https://www.ncbi.nlm.nih.gov/pubmed/37693358
http://dx.doi.org/10.3389/fendo.2023.1213711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485700/
https://www.ncbi.nlm.nih.gov/pubmed/37693358
http://dx.doi.org/10.3389/fendo.2023.1213711

Ejemplares similares